Author: wnnadmin

Oregon Legalization Campaign Purchasing At Least $2.3 Million in TV Ads

New Approach Oregon, the campaign behind the initiative to legalize cannabis which was recently certified for this November’s ballot, will be purchasing at least $2.3 million in television ads this fall, according to Liz Kaufman, the group’s Campaign Director.

Kaufman makes it clear that the $2.3 million is a base television buy, and may very likely be added to in the coming days and weeks. The group has already reserved $750,000 worth of ad space from local stations KGW and KATU, which will air between September 22nd and the November 4th election.

In conjunction with this announcement, the campaign has released a commercial (which can be seen below) featuring Richard Harris, former head of the state’s addictions and mental health division (and Executive Director of Portland’s Central City Concern). The ad is expected to run on TV soon.

If put on the ballot and approved into law, New Approach Oregon’s initiative would legalize the possession of up to 8 ounces of cannabis, the private cultivation of up to 4 cannabis plants, and would authorize state-licensed outlets to distribute the plant.


The post Oregon Legalization Campaign Purchasing At Least $2.3 Million in TV Ads appeared first on The Joint Blog.

Read More

Sante Fe Initiative to Decriminalize Cannabis Qualifies for November Ballot

An initiative to decriminalize cannabis in Santa Fe, New Mexico has officially qualified for this November’s ballot after the city’s clerk certified that enough valid signatures were submitted. The Santa Fe City Council now has the option of either passing the measure into law or putting it to a vote of the people. First, the council has scheduled a public hearing for August 27th.

In total, 10,925 signatures were submitted. Although only 5,754 of these were valid (from registered Sante Fe voters), the number surpasses the 5,673 required signatures.

If approved into law, the initiative – sponsored by ProgressNow NM and Drug Policy Action – would decriminalize the possession of up to an ounce of cannabis for those 21 and older, making it a simple $25 ticket.

If not approved by the Sante Fe City Council, it will be put to a vote on November 4th.


The post Sante Fe Initiative to Decriminalize Cannabis Qualifies for November Ballot appeared first on The Joint Blog.

Read More

Study: Cannabis May Treat Rheumatoid Arthritis

An example of rheumatoid arthritis. [WebMD]

A new study being published in the upcoming issue of the journal BMC Musculoskeletal Disorders, and e-published ahead of print by the National Institute of health, has found that a cannabinoid receptor agonist can successfully help against some of the primary symptoms of rheumatoid arthritis (RA), indicating that cannabis, which is a natural agonist to the body’s cannabinoid receptors, may provide a treatment option for the condition.

For the study, mice with RA were injected with JWH133, a selective CB2 [cannabinoid receptor type 2] agonist, and it was found that it “reduced the arthritis score, inflammatory cell infiltration, bone destruction, and anti-CII IgG1 production.”

Researchers conclude that; “The present study suggests that a selective CB2 agonist could be a new therapy for RA that inhibits production of inflammatory mediators from FLS, and osteoclastogenesis.”

The study helps to validate the results of a study released in January, which found that activation of the body’s cannabinoid receptors may provide a treatment for RA.


The post Study: Cannabis May Treat Rheumatoid Arthritis appeared first on The Joint Blog.

Read More

Cannabis May Improve Motor Symptoms, Stimulate Neuroprotective Processes In Those With Huntington’s Disease

administration of a compound meant to mimic the effects of cannabis can improve motor symptoms and stimulate neuroprotective processes in those with Huntington’s disease.

“Huntington’s disease (HD) is a devastating neurodegenerative disease characterized by a progressive decline in motor abilities, as well as in cognitive and social behaviors”, claims the study. “Most of these behavioral deficits are recapitulated in the R6/1 transgenic mouse, which can therefore be used as an experimental model to identify the neurobiological substrates of HD pathology and to design novel therapeutic approaches.”

According to researchers; “The endocannabinoid system (ECS) is a relevant candidate to participate in the etiopathology of HD as it is a key modulator of brain function, especially in areas primarily affected by HD dysfunction such as the striatum. Thus, some studies have demonstrated an association between HD progression and alterations in the expression of several ECS [endocannabinoid system] elements, thereby suggesting that improving ECS function may constitute a useful strategy to eliminate or at least delay the appearance of HD symptoms.”

In conducting the study, researchers used a cannabinoid receptor agonist (WIN 55,212) – something that cannabis naturally is – to test whether it would improve HD-like symptoms in mice.

“While acute treatment did not change the behavioral phenotype of transgenic animals, chronic administration was able to prevent the appearance of motor deficits, to increase the number of striatal huntingtin inclusions and to prevent the loss of striatal medium-sized spiny neurons, without affecting the social or cognitive alterations”, claims the study.

Researchers conclude; “These findings suggest that prolonged administration of cannabinoid receptor agonists could be an appropriate strategy for selectively improving motor symptoms and stimulating neuroprotective processes in HD patients.”

The full study can be found by clicking here.


The post Cannabis May Improve Motor Symptoms, Stimulate Neuroprotective Processes In Those With Huntington’s Disease appeared first on The Joint Blog.

Read More